OIA
GSK icon

Optimum Investment Advisors’s GSK GSK Stock Holding History

Optimum Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,000
Closed -$400 – 683
2023
Q3 		$400 Hold
1,000
– – ﹤0.01% 685
2023
Q2 		$400 Buy
+1,000
New +$35.9K ﹤0.01% 688

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Optimum Investment Advisors's GSK Position: Q3 2025 in Review

Optimum Investment Advisors sold out of GSK (GSK) in Q3 2025, closing a stake of 160 shares — an estimated $6.14K sold.

Optimum Investment Advisors first reported a position in GSK in Q3 2013 and held it in 37 quarters. The position peaked at $798K in Q4 2019. 896 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Optimum Investment Advisors reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • Optimum Investment Advisors sold 160 GSK shares in Q3 2025, an estimated $6.14K.
  • Optimum Investment Advisors first reported a position in GSK in Q3 2013 and held it in 37 quarters.
  • Optimum Investment Advisors's GSK position peaked at $798K in Q4 2019.
  • 896 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.